Envoy Medical Inc’s recent filing unveils that its Director Patel Mona Chetan acquired Company’s shares for reported $3675.0 on Jun 11 ’25. In the deal valued at $1.47 per share,2,500 shares were bought. As a result of this transaction, Patel Mona Chetan now holds 20,000 shares worth roughly $31800.0.
Then, Patel Mona Chetan bought 10,000 shares, generating $14,600 in total proceeds. Upon buying the shares at $1.46, the Director now owns 17,500 shares.
Before that, BRYNELSEN CHARLES bought 35,000 shares. Envoy Medical Inc shares valued at $57,673 were divested by the Director at a price of $1.65 per share. As a result of the transaction, BRYNELSEN CHARLES now holds 50,000 shares, worth roughly $79500.0.
Ascendiant Capital Markets initiated its Envoy Medical Inc [COCH] rating to a Buy in a research note published on June 24, 2024; the price target was $8.50.
Price Performance Review of COCH
On Tuesday, Envoy Medical Inc [NASDAQ:COCH] saw its stock jump 97.07% to $1.59. Over the last five days, the stock has gained 104.98%. Envoy Medical Inc shares have fallen nearly -47.35% since the year began. Nevertheless, the stocks have risen 11.19% over the past one year. While a 52-week high of $3.40 was reached on 05/14/25, a 52-week low of $0.74 was recorded on 10/02/25.
Levels Of Support And Resistance For COCH Stock
The 24-hour chart illustrates a support level at 1.3633, which if violated will result in even more drops to 1.1367. On the upside, there is a resistance level at 1.8533. A further resistance level may holdings at 2.1167.
How much short interest is there in Envoy Medical Inc?
A steep rise in short interest was recorded in Envoy Medical Inc stocks on 2025-09-15, growing by 84995.0 shares to a total of 0.18 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 93613.0 shares. There was a rise of 47.59%, which implies that there is a positive sentiment for the stock.